Process validation for finished products – information and data to be provided in regulatory submissions

This guideline applies to human and veterinary medicines.

Current effective version

PDF iconRevision 1 - Adopted guideline

Reference number EMA/CHMP/CVMP/QWP/BWP/70278/2012 Rev. 1
Published 28/02/2014
Effective from 29/08/2014
Keywords Process validation, continuous process verification, on-going process verification, critical process parameter, critical quality attribute, lifecycle, change control
Description This document provides guidance on the process validation information and data to be provided in regulatory submissions for the finished dosage forms of chemical medicinal products for human and veterinary use. The general principles also apply to active substances. The principles described are also applicable to biological medicinal products, but these should be considered on a case by case basis.


Document history

Revision 1
Current revision

PDF iconAdopted guideline

 

PDF iconOverview of comments

 

PDF iconDraft guideline

 

PDF iconConcept paper

In operation: 28/08/2014–present

 

Published: 28/02/2014

 

Published: 13/04/2012

 

Published: 03/03/2010

First version

PDF iconAdopted guideline

 

PDF iconAnnex II - Adopted guideline

In operation: 01/09/2001–27/08/2014

 

In operation: 01/01/2005–27/08/2014


Related content for human medicines



Related content for veterinary medicines


How useful was this page?

Add your rating